MSB 0.00% $1.10 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-525

  1. 554 Posts.
    lightbulb Created with Sketch. 59
    Could one of the kind & smart people here able to deduce what are the possible risks for next BLA submission going south again?

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.